Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters

BACKGROUND: Breast cancer pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) varies with tumor subtype. The purpose of this study was to identify an early treatment window for predicting pCR based on tumor subtype, pretreatment total hemoglobin (tHb) level, and early changes in tHb...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res
Main Authors: Zhu, Quing, Tannenbaum, Susan, Kurtzman, Scott H., DeFusco, Patricia, Ricci, Andrew, Vavadi, Hamed, Zhou, Feifei, Xu, Chen, Merkulov, Alex, Hegde, Poornima, Kane, Mark, Wang, Liqun, Sabbath, Kert
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6001175/
https://ncbi.nlm.nih.gov/pubmed/29898762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-0975-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados